Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Vaccine. 2011 Aug 22;29(45):8066–8072. doi: 10.1016/j.vaccine.2011.08.044

Table 4.

Serum HAI and MNt antibody responses to the heterologous H9N2 antigen, influenza A/Quail/Hong Kong/G1/97 (H9N2)

Age group 18–38 44–59
7.5 mcg (n=31) 30 mcg (n=30) All (n=61) 7.5 mcg (n=28) 30 mcg (n=32) All (n=60)
HAI*
 SCR (95% CI)
  Day 28 14 (4, 33) 30 (15, 49) 22 (13, 35) 21 (8, 41) 13 (4, 29) 17 (8, 29)
  Day 56 11 (2, 29) 24 (10, 44) 18 (9, 30) 12 (2, 30) 13 (4, 29) 12 (5, 23)
 GMTs (95%CI)
  Day 0 2 (2, 3) 3 (2, 3) 3 (2, 3) 4 (3, 5) 3 (3, 4) 4 (3, 4)
  Day 28 4 (3, 5) 5 (3, 7) 4 (3, 5) 7 (5, 9) 6 (5, 7) 6 (5, 8)
  Day 56 3 (3, 4) 4 (3, 5) 4 (3, 4) 5 (4, 7) 5 (4, 7) 5 (4, 6)
 SCF (95% CI)
  Day 28 1.6 (1.2, 2.0) 1.8 (1.4, 2.4) 1.7 (1.4, 2.0) 1.8 (1.4, 2.3) 1.8 (1.4, 2.3) 1.8 (1.5, 2.1)
  Day 56 1.4 (1.1, 1.7) 1.7 (1.3, 2.1) 1.5 (1.3, 1.8) 1.4 (1.1, 1.8) 1.6 (1.3, 2.0) 1.5 (1.3, 1.8)
 % with titer ≥32 (95%CI)
  Day 0 0 (0, 11) 3 (0, 17) 2 (0,9) 4 (0,18) 3 (0,16) 3 (0,12)
  Day 28 0 (0, 12) 7 (1, 22) 3 (0, 12) 7 (1, 24) 6 (1, 21) 7 (2, 16)
  Day 56 0 (0, 13) 0 (0, 12) 0 (0, 6) 4 (0, 20) 3 (0, 16) 3 (0, 12)
MNt
 SCR
  Day 28 3 (0, 17) 30 (15, 49) 17 (8, 29) 4 (0, 18) 9 (2, 25) 7 (2, 16)
  Day 56 22 (9, 42) 52 (33, 71) 38 (25, 52) 12 (2, 30) 9 (2, 25) 10 (4, 21)
 GMTs (95%CI)
  Day 0 3 (2, 4) 3 (2, 4) 3 (3, 4) 10 (7, 14) 10 (8, 12) 10 (8, 12)
  Day 28 6 (5, 7) 9 (7, 13) 7 (6, 9) 15 (10, 22) 16 (11, 22) 15 (12, 20)
  Day 56 7 (5, 9) 10 (8, 13) 8 (7, 10) 18 (12, 26) 17 (13, 23) 17 (14, 22)
 SCF (95% CI)
  Day 28 1.8 (1.6, 2.1) 2.8 (2.2, 3.6) 2.3 (2.0, 2.6) 1.5 (1.2, 1.9) 1.6 (1.1, 2.2) 1.6 (1.3, 1.9)
  Day 56 2.1 (1.7, 2.6) 3.4 (2.7, 4.3) 2.7 (2.3, 3.2) 1.8 (1.5, 2.2) 1.7 (1.3, 2.3) 1.8 (1.5, 2.1)
*

Abbreviations: HAI = hemagglutination inhibition, GMT = geometric mean titer, SCF = seroconversion factor, SCR = seroconversion rate, MNt = microneutralization